Évaluation des besoins - ASK biosimilars

Étape 1 sur 3

33%

Please specify your country of practice:(Nécessaire)

Pays

Please select the job title that best describes your role:(Nécessaire)

Hospital pharmacist (general)

Medical doctor

Nurse

Oncologist

Oncology pharmacist

Other

Please specify(Nécessaire)

How long have you worked in this field?(Nécessaire)

Less than 1 year

1 to 5 years

5 to 10 years

10 to 15 years

More than 15 years

What aspect of the background to biosimilar medications are you least confident about?(Nécessaire)

Understanding the fundamentals of protein structure and protein modification as they relate to biological medicines and biosimilars

Knowledge of the manufacturing and quality management processes for biological and biosimilar medications

Identifying the strengths and weaknesses of real-world evidence and clinical studies in the evaluation of biosimilars

Critically evaluating papers and other materials about biosimilars (including statistical models)

Other

Please specify(Nécessaire)

What administrative aspect of biosimilars do you find the most challenging?(Nécessaire)

Recognising when it is appropriate to consider a biosimilar

Evaluation of the risks vs benefits of using a biosimilar

Conducting an economic evaluation to support the use of a biosimilar

Communication with the patient

Initiating and completing successful transition to a biosimilar

Understanding local regulations on the use of biosimilars

Other

Please specify(Nécessaire)

What practical aspects of biosimilars do you find the most challenging?(Nécessaire)

Understanding the formation of anti-drug antibodies and immunogenicity

Changes to the formulation to accommodate a different route of administration from the reference product

Interpreting stability data

Concerns about pharmacovigilance and patient follow up

Other

Please specify(Nécessaire)

On what scientific topics relating to biosimilars would you like to receive additional education? (Select all that apply)(Nécessaire)

Fundamentals of biological and biosimilars medicines

Manufacturing processes

Stability and degradation factors

Emerging biosimilars

Other (please specify)

Please specify(Nécessaire)

What broader biosimilar educational topics would you like to see more of? (Select all that apply)(Nécessaire)

Communicating the suggested switch to patients

Engaging with the multidisciplinary team

Pharmacovigilance requirements

Local regulations

Building a business case for biosimilars

Case studies of successfully transitioning patients and services to biosimilars

Other (please specify)

Please specify(Nécessaire)

Which of the following educational formats do you find accessible? (Select all that apply)(Nécessaire)

Webinar series

Continuing professional development modules

Live panel debate series

Updates to the summaries of scientific papers

Small-scale ‘ask the expert’ virtual meetings to answer submitted questions

Regular newsletter summarising recent papers and educational initiatives

Other (please specify)

Please specify(Nécessaire)